Sharps Technology signs five-year syringe supply agreement with U.S. medical products company

Sharps Technology signed a five-year sales agreement with a U.S.-based supplier of medical saline and water products to supply customized 10mL SoloGard syringes from its EU facility, valued at over $50 million in new revenue.

“Creating a strategic partnership with the customer and selling out production capacity at the Hungary plant for the next five years is a historic accomplishment for Sharps”globenewswire.com

• 1 source
• globenewswire.comSharps Technology Enters Into a Five-Year Sales AgreementSharps Technology IncJul 25, 2024

Summarized from public sources; check the original articles before acting on it.